https://www.pharmiweb.com/press-release/2022-12-09/azura-ophthalmics-presents-positive-results-from-phase-2b-clinical-trial-of-azr-md-001-in-meibomian
0
0
12/9/22 at 4:09pm
Organization
PharmiWeb.com
Author
Businesswire
TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced that positive 3-month effic…
Create an account
or login to join the discussion